Jolene Kay Berg
Health Net(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Antibiotics Pharmacokinetics and Efficacy, Gastrointestinal motility and disorders, Iron Metabolism and Disorders, Pancreatic function and diabetes
Most-Cited Works
- → Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes(2013)178 cited
- → Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir(2009)160 cited
- → Cefiderocol, a Siderophore Cephalosporin for Gram‐Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment(2016)101 cited
- → Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease(2019)74 cited
- → Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus(2015)66 cited
- → Effects of exenatide twice daily versus sitagliptin on 24‐h glucose, glucoregulatory and hormonal measures: a randomized, double‐blind, crossover study(2011)56 cited
- → Pharmacokinetics and Pharmacodynamics of Subcutaneous Recombinant Parathyroid Hormone (1–84) in Patients With Hypoparathyroidism: An Open-Label, Single-Dose, Phase I Study(2014)52 cited
- → Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial(2014)47 cited
- → Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function(2017)46 cited
- → Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics(2017)36 cited